Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 12, 2012, Pages 1336-1342

  Horlbeck, Fritz W ^a   Mellert, Fritz ^a   Kreuz, Jens ^a   Nickenig, Georg ^a   Schwab, Joerg O ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

battery longevity; cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillator; ventricular pacing

Indexed keywords

ADULT; AGED; ARTICLE; BIBLIOGRAPHIC DATABASE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEVICES; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIFESPAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; TREATMENT DURATION;

CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 84871225457     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02408.x     Document Type: Article

References (36)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
2. Kuck KH, Cappato R, Siebels J, Ruppel R,: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754. (Pubitemid 30648765)
3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B,: Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302. (Pubitemid 30158618)
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
6. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA,: Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990; 16: 381-386. (Pubitemid 20245857)
7. de Marchena E, Chakko S, Fernandez P, Villa A, Cooper D, Wozniak P, Cruz J, Thurer RJ, Kessler KM, Myerburg RJ,: Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease. Am J Cardiol 1991; 67: 812-816.
8. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W,: Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005; 28: 926-932. (Pubitemid 43960867)
9. Sanders GD, Hlatky MA, Owens DK,: Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353: 1471-1480. (Pubitemid 41400921)
10. Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S,: Cost-effectiveness of cardiac resynchronization therapy: Results from the CARE-HF trial. Eur Heart J 2005; 26: 2681-2688. (Pubitemid 41746691)
11. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH,: Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006; 114: 135-142. (Pubitemid 44420745)
12. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Moss AJ,: The cost effectiveness of implantable cardioverter-defibrillators: Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006; 47: 2310-2318. (Pubitemid 43795065)
13. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K,: Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007; 115: 2474-2480. (Pubitemid 46763220)
14. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ,: Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365. (Pubitemid 351443082)
15. Ramachandra I,: Impact of ICD battery longevity on need for device replacements-insights from a Veterans Affairs database. Pacing Clin Electrophysiol 2010; 33: 314-319.
16. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV,: Predictors of short term complications after ICD replacement: Results from the Ontario ICD database. Circ Arrhythm Electrophysiol 2011; 4: 136-142.
17. Schaer BA, Koller MT, Sticherling C, Altmann D, Joerg L, Osswald S,: Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 2009; 6: 1737-1743.
18. Benditt DG, Sakaguchi S, Jhanjee R,: Right ventricular pacing in MADIT-II: A risk factor for increased mortality, or mainly a marker of increased risk. Heart Rhythm 2011; 8: 219-220.
19. Barsheshet A, Moss AJ, McNitt S, Jons C, Glikson M, Klein HU, Huang DT, Steinberg JS, Brown MW, Zareba W, Goldenberg I,: Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm 2011; 8: 212-218.
20. Hauser RG, Hayes DL, Epstein AE, Cannom DS, Vlay SC, Song SL, Tyers GF,: Multicenter experience with failed and recalled implantable cardioverter- defibrillator pulse generators. Heart Rhythm 2006; 3: 640-644.
21. Knops P, Theuns DA, Res JC, Jordaens L,: Analysis of implantable defibrillator longevity under clinical circumstances: Implications for device selection. Pacing Clin Electrophysiol 2009; 32: 1276-1285.
22. Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C, Diemberger I, Boriani G,: Longevity of implantable cardioverter-defibrillators: Implications for clinical practice and health care systems. Europace 2008; 10: 1288-1295.
23. Aidelsburger P, Grabein K, Klauss V, Wasem J,: Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective. Clin Res Cardiol 2008; 97: 89-97. (Pubitemid 351257992)
24. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG,: The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007; 28: 42-51. (Pubitemid 46134956)
25. Bertoldi EG, Rohde LE, Zimerman LI, Pimentel M, Polanczyk CA,: Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: The perspective of a middle-income country's public health system. Int J Cardiol 2011: doi: 10.1016/j.ijcard.2011.06.046.
26. Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC,: Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: Insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Eur Heart J 2011; 32: 1631-1639.
27. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A,: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123. (Pubitemid 36014128)
28. Sweeney MO, Ellenbogen KA, Casavant D, Betzold R, Sheldon T, Tang F, Mueller M, Lingle J,: Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. J Cardiovasc Electrophysiol 2005; 16: 811-817. (Pubitemid 41623769)
29. Xue-Jun R, Zhihong H, Ye W, Huifeng D, Jinrong Z, Fang C, Jihong G,: A clinical comparison between a new dual-chamber pacing mode-AAIsafeR and DDD mode. Am J Med Sci 2010; 339: 145-147.
30. Kolb C, Schmidt R, Dietl JU, Weyerbrock S, Morgenstern M, Fleckenstein M, Beier T, Von Bary C, Mackes KG, Widmaier J, Kreuzer J, Semmler V, Zrenner B,: Reduction of right ventricular pacing with advanced atrioventricular search hysteresis: Results of the PREVENT study. Pacing Clin Electrophysiol 2011; 34: 975-983.
31. Olshansky B, Day J, McGuire M, Hahn S, Brown S, Lerew DR,: Reduction of right ventricular pacing in patients with dual-chamber ICDs. Pacing Clin Electrophysiol 2006; 29: 237-243. (Pubitemid 43881398)
32. Thijssen J, Borleffs CJ, van Rees JB, Man S, de Bie MK, Venlet J, van der Velde ET, van Erven L, Schalij MJ,: Implantable cardioverter-defibrillator longevity under clinical circumstances: An analysis according to device type, genen, and manufacturer. Heart Rhythm 2012; 9: 513-519.
33. Gilliam FR, Hayes DL, Boehmer JP, Day J, Heidenreich PA, Seth M, Jones PW, Stein KM, Saxon LA,: Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: The ALTITUDE REDUCES study. J Cardiovasc Electrophysiol 2011; 22: 1023-1029.
34. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV,: Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 2010; 55: 774-782.
35. Lyman S, Sedrakyan A, Do H, Razzano R, Mushlin AI,: Infrequent physician use of implantable cardioverter-defibrillators risks patient safety. Heart 2011; 97: 1655-1660.
36. Wild DM, Fisher JD, Kim SG, Ferrick KJ, Gross JN, Palma EC,: Pacemakers and implantable cardioverter defibrillators: Device longevity is more important than smaller size: The patient's viewpoint. Pacing Clin Electrophysiol 2004; 27: 1526-1529. (Pubitemid 39557688)